The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EMN 2018 | Promising new therapies for MM treatment
Robert Kyle, MD, of the Mayo Clinic, Rochester, MN, talks about examples of new therapies that are currently under development and investigation for the treatment of multiple myeloma (MM). Prof. Kyle puts a particular emphasis on CAR T-cell therapy, before mentioning several drugs that have been introduced and used in MM treatment over the course of the past 15 years. This interview took place at the 1st European Myeloma Network (EMN) Meeting 2018, in Turin, Italy.
